Yumanity Therapeutics Competitors and Similar CompaniesClear all

Yumanity Therapeutics's competitors and similar companies include Vertex Pharmaceuticals, BioMarin Pharmaceutical, CSL Behring and Fujifilm Diosynth Biotechnologies.

	Yumanity Therapeutics Yumanity Therapeutics (formerly known as Proteostasis Therapeutics) is a biopharmaceutical company developing therapeutics to treat diseases caused by an imbalance in the proteostasis network.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.	CSL Behring CSL Behring is a provider of life-saving medicines.	Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
Founding Date	Founding Date 2014	Founding Date 1989	Founding Date 1997	Founding Date 1904	Founding Date 2011
Type	Type Public	Type Public	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Boston, US HQ	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US
Employees	Employees 4434% decrease	Employees 5,40013% increase	Employees 3,0015% increase	Employees 7,5692% decrease	Employees 5,3942% increase
Valuation ($)	Valuation ($) 15.7 m	Valuation ($) 121.4 b	Valuation ($) 13.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $3.2b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods $717.4m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit $2.5b (FY, 2025)	Gross profit $4.5b (FY, 2020)	Gross profit N/A
Net income	Net income ($17.1m) (FY, 2024)	Net income N/A	Net income $348.9m (FY, 2025)	Net income N/A	Net income N/A
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications N/A	Patent Applications 426 (FY, 2016)	Patent Applications 3 (Dec, 2020)	Patent Applications N/A
Funding
Total funding raised	Total funding raised $ 82m	Total funding raised $ 2.4m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 850m